Found 7 matching trials
Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema PHASE3 Primary Objective - To assess the relative efficacy of two dose levels of C...
Show More Location
Asthma and Allergy Associates, P.C
Learn More & Join Trial
Berinert (C1INH) vs Placebo for DGF/IRI PHASE1 This is a Phase I/II double-blind, randomized, placebo-controlled study ass...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study) PHASE3 Hereditary angioedema (HAE) is a rare disorder characterized by congenital ...
Show More Location
Contact CSL Behring for facility details
Learn More & Join Trial
Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE) PHASE3 The purpose of this study is to determine if an investigational treatment i...
Show More Location
Toyohashi Municipal Hospital
Learn More & Join Trial
Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert PHASE4 This is a prospective, international, multi-center, non-randomized, single ...
Show More Location
MHAT "Tsaritsa Yoanna"
Learn More & Join Trial
CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 PHASE2 The objectives of this study were to evaluate: (1) the dose response and (2...
Show More Location
Asthma & Allergy Associates, P.C.
Learn More & Join Trial
Evaluation of the Effects of Bradykinin Antagonists on Pulmonary Manifestations of COVID-19 Infections (AntagoBrad-Cov Study). PHASE2 The main objective of this study is to evaluate the efficacy of human C1 in...
Show More Location
Hôpital Privé de Parly II
Learn More & Join Trial